Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Thomas Whitehill

Concepts (238)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Vena Cava Filters
2
2000
44
0.440
Why?
Pulmonary Embolism
2
2000
151
0.400
Why?
Femoral Artery
5
2008
159
0.350
Why?
Diagnostic Techniques, Cardiovascular
1
2002
17
0.300
Why?
Ischemia
4
2008
308
0.300
Why?
Vascular Surgical Procedures
2
2002
229
0.300
Why?
Risk Management
1
2002
69
0.290
Why?
Preoperative Care
2
2002
340
0.260
Why?
Arteriosclerosis
2
1998
131
0.260
Why?
Estrogen Replacement Therapy
2
1998
104
0.250
Why?
Aortic Diseases
2
1998
80
0.250
Why?
Iliac Aneurysm
2
1998
3
0.250
Why?
Fibromuscular Dysplasia
1
1997
5
0.220
Why?
Arterial Occlusive Diseases
5
2000
116
0.220
Why?
Mesenteric Arteries
1
1997
15
0.210
Why?
Angioplasty, Balloon, Laser-Assisted
1
1997
1
0.210
Why?
Thrombophlebitis
1
1996
10
0.200
Why?
Vascular Patency
4
2008
102
0.190
Why?
Femoral Vein
2
2008
23
0.190
Why?
Intermittent Claudication
1
1997
192
0.170
Why?
Iliac Artery
2
1991
37
0.170
Why?
Blood Vessel Prosthesis
2
1991
52
0.170
Why?
Lipids
2
1998
564
0.160
Why?
Informed Consent
1
2014
125
0.160
Why?
Comprehension
1
2014
125
0.160
Why?
Polytetrafluoroethylene
1
1991
28
0.140
Why?
Plethysmography
2
1988
134
0.130
Why?
Ovariectomy
3
2000
116
0.130
Why?
Patient Satisfaction
1
2014
504
0.130
Why?
Amputation
2
2003
138
0.130
Why?
Fluoresceins
2
1988
53
0.120
Why?
Thrombolytic Therapy
2
2003
70
0.120
Why?
Muscle, Smooth, Vascular
5
1998
511
0.120
Why?
Axillary Vein
1
2008
3
0.120
Why?
Splanchnic Circulation
1
1988
16
0.120
Why?
Arteriovenous Shunt, Surgical
1
2008
19
0.110
Why?
Intestines
2
1988
273
0.110
Why?
Carotid Artery Injuries
1
1988
40
0.110
Why?
Vertebral Artery
1
1988
28
0.110
Why?
Upper Extremity
1
2008
59
0.110
Why?
Venous Thrombosis
2
2000
121
0.110
Why?
Wounds, Penetrating
1
1988
62
0.110
Why?
Tunica Intima
2
1998
92
0.110
Why?
Brachial Artery
1
2008
148
0.100
Why?
Aorta
4
1998
319
0.100
Why?
Equipment Design
2
2000
522
0.100
Why?
Wounds, Nonpenetrating
1
1988
187
0.100
Why?
Interleukin-10
2
1998
321
0.100
Why?
Renal Dialysis
1
2008
273
0.090
Why?
Aged, 80 and over
7
2003
5500
0.090
Why?
Anastomosis, Surgical
3
1997
101
0.090
Why?
Leg
2
2003
271
0.090
Why?
Humans
27
2014
89008
0.090
Why?
Radiography
2
1998
807
0.090
Why?
Kidney Failure, Chronic
1
2008
379
0.080
Why?
Sheep
4
2000
730
0.080
Why?
Ultrasonography
1
1988
791
0.080
Why?
Cell Division
4
1998
921
0.080
Why?
Aged
10
2014
16035
0.080
Why?
Treatment Outcome
6
2008
7243
0.080
Why?
Middle Aged
10
2014
23490
0.070
Why?
Treatment Refusal
1
2002
83
0.070
Why?
Male
18
2014
50191
0.070
Why?
Aneurysm, Ruptured
2
1998
21
0.070
Why?
Hemangioendothelioma, Epithelioid
1
2001
6
0.070
Why?
Vascular Neoplasms
1
2001
18
0.070
Why?
Dogs
4
1991
475
0.070
Why?
General Surgery
1
2002
104
0.070
Why?
Hemostatic Techniques
1
2001
39
0.070
Why?
Peripheral Vascular Diseases
1
2003
177
0.070
Why?
Lower Extremity
1
2003
165
0.070
Why?
Female
17
2014
50621
0.070
Why?
Raloxifene Hydrochloride
1
2000
19
0.070
Why?
Catheterization, Peripheral
1
2001
60
0.070
Why?
Activities of Daily Living
1
2003
342
0.070
Why?
Selective Estrogen Receptor Modulators
1
2000
24
0.060
Why?
Chemoprevention
1
2000
64
0.060
Why?
Fibroblast Growth Factors
2
1998
155
0.060
Why?
Suture Techniques
1
2001
116
0.060
Why?
Forefoot, Human
1
1999
4
0.060
Why?
Toes
1
1999
11
0.060
Why?
Diabetic Foot
1
1999
19
0.060
Why?
Counseling
1
2002
305
0.060
Why?
Activated Protein C Resistance
1
1998
2
0.060
Why?
Heparin
1
2000
191
0.060
Why?
Smoking Cessation
1
2002
305
0.060
Why?
Warfarin
1
2000
141
0.060
Why?
Safety
1
2000
269
0.060
Why?
Ligation
2
2008
97
0.060
Why?
Receptors, Interferon
1
1998
41
0.060
Why?
Coronary Vessels
1
2000
204
0.060
Why?
Thrombophilia
1
1998
84
0.060
Why?
Arteriovenous Fistula
1
1998
18
0.060
Why?
Retrospective Studies
6
2008
7746
0.050
Why?
Aortography
1
1998
50
0.050
Why?
Reoperation
3
2008
499
0.050
Why?
Retroperitoneal Fibrosis
1
1997
1
0.050
Why?
Antibodies, Anticardiolipin
1
1997
9
0.050
Why?
Sigmoid Neoplasms
1
1997
3
0.050
Why?
Biocompatible Materials
1
2000
246
0.050
Why?
Neurofibromatoses
1
1997
3
0.050
Why?
Celiac Artery
1
1997
8
0.050
Why?
Thromboangiitis Obliterans
1
1997
3
0.050
Why?
Embolization, Therapeutic
1
1998
117
0.050
Why?
Carcinoid Tumor
1
1997
16
0.050
Why?
Vena Cava, Inferior
1
1998
55
0.050
Why?
Diabetes Complications
1
1999
233
0.050
Why?
Blood Vessels
1
1998
164
0.050
Why?
Vasodilation
1
2000
433
0.050
Why?
Coronary Disease
1
2000
444
0.050
Why?
Neoplastic Cells, Circulating
1
1997
59
0.050
Why?
Anticoagulants
1
2000
410
0.050
Why?
Carotid Stenosis
1
1996
46
0.050
Why?
Adult
8
2014
25872
0.050
Why?
Sepsis
1
1999
341
0.040
Why?
Estrogens
1
1998
283
0.040
Why?
Lac Operon
1
1994
57
0.040
Why?
Transforming Growth Factor beta
1
1998
491
0.040
Why?
Regional Blood Flow
2
1999
434
0.040
Why?
Internship and Residency
1
2002
663
0.040
Why?
Stents
1
1998
370
0.040
Why?
Interferon-gamma
1
1998
771
0.040
Why?
Capillaries
1
1994
128
0.040
Why?
Decision Making
1
2000
598
0.040
Why?
Animals
9
2000
32201
0.040
Why?
Time Factors
4
2008
6419
0.040
Why?
Mental Recall
1
2014
223
0.040
Why?
Coronary Artery Disease
1
1998
527
0.040
Why?
Thrombectomy
2
2003
30
0.040
Why?
Perception
1
2014
225
0.040
Why?
Estradiol
3
2000
387
0.040
Why?
Knee
1
1991
47
0.040
Why?
Endothelium, Vascular
2
1998
862
0.040
Why?
Jugular Veins
1
1991
39
0.030
Why?
Graft Occlusion, Vascular
1
1991
50
0.030
Why?
Platelet Aggregation
1
1991
76
0.030
Why?
Clinical Trials as Topic
1
1996
947
0.030
Why?
Carotid Arteries
1
1991
160
0.030
Why?
Surface Properties
1
1991
390
0.030
Why?
Prosthesis Design
1
1991
238
0.030
Why?
Aspirin
1
1991
234
0.030
Why?
Fluorescein
1
1988
23
0.030
Why?
Hemangioma, Cavernous
1
1988
19
0.030
Why?
Arteriovenous Malformations
1
1988
19
0.030
Why?
Wound Healing
2
2003
307
0.030
Why?
Hyperplasia
2
1998
160
0.030
Why?
Tomography, X-Ray Computed
1
1998
2046
0.030
Why?
Hemangioma
1
1988
37
0.030
Why?
Tissue and Organ Harvesting
1
2008
61
0.030
Why?
Arm
1
1988
92
0.030
Why?
Rheology
1
1988
88
0.030
Why?
Follow-Up Studies
2
1999
4098
0.030
Why?
Microsurgery
1
1987
37
0.030
Why?
Muscle, Skeletal
1
1994
1282
0.020
Why?
Cell Adhesion
2
1998
429
0.020
Why?
Patient Selection
1
2008
617
0.020
Why?
Surveys and Questionnaires
1
2014
3383
0.020
Why?
Evaluation Studies as Topic
2
1996
258
0.020
Why?
Tumor Necrosis Factor-alpha
2
1998
1192
0.020
Why?
Artificial Limbs
1
2003
52
0.020
Why?
Catheterization
1
2003
194
0.020
Why?
Aneurysm, False
1
2001
38
0.020
Why?
Angioplasty
1
2001
36
0.020
Why?
Nitroglycerin
1
2000
21
0.020
Why?
Equipment Failure
1
2001
129
0.020
Why?
Angiography
1
2001
163
0.020
Why?
Internal Medicine
1
2002
185
0.020
Why?
Radiography, Interventional
1
2001
101
0.020
Why?
Injections, Subcutaneous
1
2000
158
0.020
Why?
Heart Function Tests
1
2000
61
0.020
Why?
Physician's Role
1
2002
191
0.020
Why?
Toe Joint
1
1999
6
0.020
Why?
Recovery of Function
1
2003
456
0.020
Why?
Young Adult
1
2014
7691
0.020
Why?
Pulse
1
1999
35
0.020
Why?
Metatarsal Bones
1
1999
16
0.020
Why?
Pulsatile Flow
1
1999
59
0.020
Why?
Debridement
1
1999
87
0.010
Why?
Cells, Cultured
2
1998
4208
0.010
Why?
Walking
1
2003
389
0.010
Why?
Thrombosis
1
2001
229
0.010
Why?
Rupture, Spontaneous
1
1998
19
0.010
Why?
Comorbidity
1
2003
1316
0.010
Why?
Cholesterol
1
2000
367
0.010
Why?
Luteinizing Hormone
1
1998
161
0.010
Why?
Aortic Rupture
1
1998
19
0.010
Why?
Aorta, Abdominal
1
1998
39
0.010
Why?
Family Practice
1
2002
408
0.010
Why?
Prostaglandins
1
1998
101
0.010
Why?
Coronary Angiography
1
2000
288
0.010
Why?
Magnetic Resonance Imaging
1
1988
2338
0.010
Why?
Growth Substances
1
1998
159
0.010
Why?
Aortic Aneurysm, Abdominal
1
1998
58
0.010
Why?
Radiographic Image Enhancement
1
1998
77
0.010
Why?
Vasodilator Agents
1
2000
324
0.010
Why?
Fibroblast Growth Factor 2
1
1998
107
0.010
Why?
Postoperative Complications
2
2003
1721
0.010
Why?
Outcome Assessment (Health Care)
1
2003
844
0.010
Why?
Cell Count
1
1998
350
0.010
Why?
Fatal Outcome
1
1998
291
0.010
Why?
Recurrence
1
1999
805
0.010
Why?
Cerebral Angiography
1
1996
67
0.010
Why?
Ultrasonography, Doppler, Duplex
1
1996
37
0.010
Why?
Leukocytes
1
1998
252
0.010
Why?
Endarterectomy, Carotid
1
1996
33
0.010
Why?
Aorta, Thoracic
1
1998
222
0.010
Why?
Costs and Cost Analysis
1
1996
202
0.010
Why?
Extracellular Matrix
1
1998
292
0.010
Why?
Microinjections
1
1994
120
0.010
Why?
Patient Readmission
1
1999
446
0.010
Why?
Contrast Media
1
1998
345
0.010
Why?
Magnetic Resonance Angiography
1
1996
157
0.010
Why?
Hindlimb
1
1994
132
0.010
Why?
Transduction, Genetic
1
1994
135
0.010
Why?
Quality of Life
1
2003
1458
0.010
Why?
Microcirculation
1
1994
144
0.010
Why?
Rats, Wistar
1
1994
428
0.010
Why?
Immunohistochemistry
1
1998
1841
0.010
Why?
Blood Pressure
1
1999
1507
0.010
Why?
Stress, Mechanical
1
1994
398
0.010
Why?
Cardiac Surgical Procedures
1
1998
491
0.010
Why?
Nitric Oxide
1
1998
841
0.010
Why?
Hospitalization
1
1999
1118
0.010
Why?
Anti-Bacterial Agents
1
1999
1024
0.010
Why?
Predictive Value of Tests
1
1996
1657
0.010
Why?
T-Lymphocytes
1
1998
1565
0.010
Why?
Disease Models, Animal
1
2000
3380
0.010
Why?
Cytokines
1
1998
1745
0.010
Why?
Actuarial Analysis
1
1988
37
0.010
Why?
Omentum
1
1987
7
0.010
Why?
Infrared Rays
1
1987
20
0.010
Why?
Adolescent
2
1998
14595
0.010
Why?
Risk Factors
1
2000
7226
0.010
Why?
Ultrasonics
1
1987
79
0.010
Why?
Prospective Studies
1
1996
4580
0.010
Why?
Rats
1
1994
6670
0.010
Why?
Algorithms
1
1988
1268
0.000
Why?
Infant, Newborn
1
1988
4256
0.000
Why?
Whitehill's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2019 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)